{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T13:48:49Z","timestamp":1794923329174,"version":"4.9.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.metabol.2024.155914","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T21:48:28Z","timestamp":1713476908000},"page":"155914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["O-GlcNAcylation promotes the progression of nonalcoholic fatty liver disease by upregulating the expression and function of CD36"],"prefix":"10.1016","volume":"156","author":[{"given":"Hanlong","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shupei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaofang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzuo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2024.155914_bb0005","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.155914_bb0010","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2024.155914_bb0015","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2024.155914_bb0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2024.155914_bb0025","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","article-title":"Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2024.155914_bb0030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41575-020-00408-y","article-title":"Therapeutic pipeline in nonalcoholic steatohepatitis","volume":"18","author":"Vuppalanchi","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2024.155914_bb0035","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.2337\/db14-0369","article-title":"Free fatty acid uptake in humans with CD36 deficiency","volume":"63","author":"Hames","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2024.155914_bb0040","doi-asserted-by":"crossref","first-page":"32523","DOI":"10.1074\/jbc.M003826200","article-title":"Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice","volume":"275","author":"Coburn","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2024.155914_bb0045","doi-asserted-by":"crossref","first-page":"re3","DOI":"10.1126\/scisignal.272re3","article-title":"CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior","volume":"2","author":"Silverstein","year":"2009","journal-title":"Sci Signal"},{"key":"10.1016\/j.metabol.2024.155914_bb0050","first-page":"10","article-title":"CD36 signal transduction in metabolic diseases: novel insights and therapeutic targeting","author":"Karunakaran","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.metabol.2024.155914_bb0055","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211314","article-title":"CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate","volume":"219","author":"Chen","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.metabol.2024.155914_bb0060","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","article-title":"Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.metabol.2024.155914_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2018.04.007","article-title":"Transfer of cell-surface antigens by scavenger receptor CD36 promotes thymic regulatory T cell receptor repertoire development and allo-tolerance","volume":"48","author":"Perry","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.metabol.2024.155914_bb0070","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.bbalip.2016.03.015","article-title":"CD36 actions in the heart: lipids, calcium, inflammation, repair and more?","volume":"1861","author":"Abumrad","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2024.155914_bb0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/eci.12192","article-title":"Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease","volume":"44","author":"Garcia-Monzon","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.metabol.2024.155914_bb0080","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.bbadis.2011.01.003","article-title":"Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease","volume":"1812","author":"Gaemers","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2024.155914_bb0085","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jhep.2018.04.006","article-title":"CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis","volume":"69","author":"Zhao","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2024.155914_bb0090","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2010.222844","article-title":"Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C","volume":"60","author":"Miquilena-Colina","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2024.155914_bb0095","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nrm.2017.22","article-title":"Protein O-GlcNAcylation: emerging mechanisms and functions","volume":"18","author":"Yang","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.metabol.2024.155914_bb0100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.tem.2013.02.002","article-title":"Cracking the O-GlcNAc code in metabolism","volume":"24","author":"Ruan","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2024.155914_bb0105","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1042\/CS20150777","article-title":"High-fat diet increases O-GlcNAc levels in cerebral arteries: a link to vascular dysfunction associated with hyperlipidaemia\/obesity?","volume":"130","author":"Lima","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.metabol.2024.155914_bb0110","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fendo.2014.00221","article-title":"O-GlcNAc: a bittersweet switch in liver","volume":"5","author":"Zhang","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metabol.2024.155914_bb0115","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.7150\/thno.34024","article-title":"Fatty acid-induced CD36 expression via O-GlcNAcylation drives gastric cancer metastasis","volume":"9","author":"Jiang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.metabol.2024.155914_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018417","article-title":"Acute regulation of cardiac metabolism by the hexosamine biosynthesis pathway and protein O-GlcNAcylation","volume":"6","author":"Laczy","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2024.155914_bb0125","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/hep.24376","article-title":"Endpoints and clinical trial design for nonalcoholic steatohepatitis","volume":"54","author":"Sanyal","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.155914_bb0130","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2024.155914_bb0135","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1053\/j.gastro.2005.09.004","article-title":"NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis","volume":"129","author":"Dela Pena","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2024.155914_bb0140","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/jth.12712","article-title":"Exosome poly-ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro-atherothombotic cellular functions","volume":"12","author":"Srikanthan","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.metabol.2024.155914_bb0145","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1074\/mcp.R113.029751","article-title":"Regulation of protein degradation by O-GlcNAcylation: crosstalk with ubiquitination","volume":"12","author":"Ruan","year":"2013","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.metabol.2024.155914_bb0150","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1021\/bi035743m","article-title":"Long-chain fatty acid uptake into adipocytes depends on lipid raft function","volume":"43","author":"Pohl","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.metabol.2024.155914_bb0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.biochi.2016.12.007","article-title":"From fat to FAT (CD36\/SR-B2): understanding the regulation of cellular fatty acid uptake","volume":"136","author":"Glatz","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.metabol.2024.155914_bb0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-nutr-071812-161220","article-title":"Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism","volume":"34","author":"Pepino","year":"2014","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.metabol.2024.155914_bb0165","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.metabol.2024.155914_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2022.11.013","article-title":"Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development","volume":"56","author":"Wang","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.metabol.2024.155914_bb0175","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1172\/JCI42823","article-title":"CD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs","volume":"120","author":"Li","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2024.155914_bb0180","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/CIRCRESAHA.119.315833","article-title":"Mitochondrial metabolic reprogramming by CD36 signaling drives macrophage inflammatory responses","volume":"125","author":"Chen","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2024.155914_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104714","article-title":"Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases","volume":"94","author":"Dewidar","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.metabol.2024.155914_bb0190","first-page":"0275","article-title":"Protective and adverse roles of DDX3X in different cell types in nonalcoholic steatohepatitis progression","volume":"6","author":"Yang","year":"2023","journal-title":"Research (Wash D C)"},{"key":"10.1016\/j.metabol.2024.155914_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155642","article-title":"Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States","volume":"146","author":"Golabi","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2024.155914_bb0200","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3389\/fendo.2018.00522","article-title":"Real talk: the inter-play between the mTOR, AMPK, and hexosamine biosynthetic pathways in cell signaling","volume":"9","author":"Cork","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metabol.2024.155914_bb0205","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/liv.15812","article-title":"Protein O-GlcNAcylation: the sweet hub in liver metabolic flexibility from a (patho)physiological perspective","volume":"44","author":"Hu","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.metabol.2024.155914_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155612","article-title":"Increased expression of sodium-glucose cotransporter 2 and O-GlcNAcylation in hepatocytes drives non-alcoholic steatohepatitis","volume":"145","author":"Chun","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2024.155914_bb0215","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jhep.2018.01.035","article-title":"Prolactin improves hepatic steatosis via CD36 pathway","volume":"68","author":"Zhang","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2024.155914_bb0220","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1478-3231.2010.02248.x","article-title":"Apoptosis is associated with CD36\/fatty acid translocase upregulation in non-alcoholic steatohepatitis","volume":"30","author":"Bechmann","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.metabol.2024.155914_bb0225","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.2337\/db07-0907","article-title":"Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity","volume":"56","author":"Koonen","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2024.155914_bb0230","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/en.2015-1866","article-title":"Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice","volume":"157","author":"Wilson","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2024.155914_bb0235","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbagen.2009.07.018","article-title":"O-linked beta-N-acetylglucosamine (O-GlcNAc): extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress","volume":"1800","author":"Butkinaree","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2024.155914_bb0240","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1073\/pnas.111099998","article-title":"O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability","volume":"98","author":"Yang","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2024.155914_bb0245","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41467-019-13601-8","article-title":"O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth","volume":"11","author":"Nie","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2024.155914_bb0250","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3233\/JAD-140096","article-title":"O-GlcNAcylation promotes non-amyloidogenic processing of amyloid-beta protein precursor via inhibition of endocytosis from the plasma membrane","volume":"44","author":"Chun","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.metabol.2024.155914_bb0255","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/35036052","article-title":"Lipid rafts and signal transduction","volume":"1","author":"Simons","year":"2000","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.metabol.2024.155914_bb0260","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1091\/mbc.e04-07-0616","article-title":"FAT\/CD36-mediated long-chain fatty acid uptake in adipocytes requires plasma membrane rafts","volume":"16","author":"Pohl","year":"2005","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.metabol.2024.155914_bb0265","doi-asserted-by":"crossref","first-page":"13444","DOI":"10.1021\/acs.jpcb.1c09419","article-title":"Site-specific stabilization and destabilization of alpha helical peptides upon phosphorylation and O-GlcNAcylation","volume":"125","author":"Rani","year":"2021","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.metabol.2024.155914_bb0270","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0092-8674(03)00974-7","article-title":"O-GlcNAc modification is an endogenous inhibitor of the proteasome","volume":"115","author":"Zhang","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2024.155914_bb0275","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.1074\/jbc.M800008200","article-title":"Opposite regulation of CD36 ubiquitination by fatty acids and insulin: effects on fatty acid uptake","volume":"283","author":"Smith","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2024.155914_bb0280","doi-asserted-by":"crossref","first-page":"25201","DOI":"10.1074\/jbc.M111.233551","article-title":"Luminal lipid regulates CD36 levels and downstream signaling to stimulate chylomicron synthesis","volume":"286","author":"Tran","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2024.155914_bb0285","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1517\/14656566.2014.876992","article-title":"New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease","volume":"15","author":"Sahebkar","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.metabol.2024.155914_bb0290","first-page":"0276","article-title":"Herpetrione, a new type of PPARalpha ligand as a therapeutic strategy against nonalcoholic steatohepatitis","volume":"6","author":"Linghu","year":"2023","journal-title":"Research (Wash D C)"},{"key":"10.1016\/j.metabol.2024.155914_bb0295","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","article-title":"Pathogenesis of nonalcoholic steatohepatitis","volume":"150","author":"Machado","year":"2016","journal-title":"Gastroenterology"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049524001409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049524001409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T19:45:24Z","timestamp":1718221524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049524001409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":59,"alternative-id":["S0026049524001409"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2024.155914","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"O-GlcNAcylation promotes the progression of nonalcoholic fatty liver disease by upregulating the expression and function of CD36","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2024.155914","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155914"}}